Biology of Cholangiocytes: From Bench to Bedside

被引:21
|
作者
Yoo, Kyo-Sang [1 ]
Lim, Woo Taek [2 ]
Choi, Ho Soon [1 ]
机构
[1] Hanyang Univ, Coll Med, Dept Internal Med, 222 Wangsimni Ro, Seoul 04763, South Korea
[2] Korea Univ, Sch Med, Seoul, South Korea
关键词
Cholangiocyte; Biology; Cholangiopathy; Transport; Receptors; PRIMARY BILIARY-CIRRHOSIS; GALLBLADDER EPITHELIAL-CELLS; DUCT-LIGATED RATS; PRIMARY SCLEROSING CHOLANGITIS; CELLULAR CHOLESTEROL EFFLUX; CULTURED HUMAN; BILE-ACID; FUNCTIONAL-HETEROGENEITY; ADRENERGIC DENERVATION; STEM/PROGENITOR CELLS;
D O I
10.5009/gnl16033
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cholangiocytes, the lining epithelial cells in bile ducts, are an important subset of liver cells. They are activated by endogenous and exogenous stimuli and are involved in the modification of bile volume and composition. They are also involved in damaging and repairing the liver. Cholangiocytes have many functions including bile production. They are also involved in transport processes that regulate the volume and composition of bile. Cholangiocytes undergo proliferation and cell death under a variety of conditions. Cholangiocytes have functional and morphological heterogenecity. The immunobiology of cholangiocytes is important, particularly for understanding biliary disease. Secretion of different proinflammatory mediators, cytokines, and chemokines suggests the major role that cholangiocytes play in inflammatory reactions. Furthermore, paracrine secretion of growth factors and peptides mediates extensive cross-talk with other liver cells, including hepatocytes, stellate cells, stem cells, subepithelial myofibroblasts, endothelial cells, and inflammatory cells. Cholangiopathy refers to a category of chronic liver diseases whose primary disease target is the cholangiocyte. Cholangiopathy usually results in end-stage liver disease requiring liver transplant. We summarize the biology of cholangiocytes and redefine the concept of cholangiopathy. We also discuss the recent progress that has been made in understanding the pathogenesis of cholangiopathy and how such progress has influenced therapy.
引用
收藏
页码:687 / 698
页数:12
相关论文
共 50 条
  • [21] From bench to bedside
    Colin L Verdant
    Critical Care, 16
  • [22] From bench to bedside
    Filipp, Fabian
    Fischer, Alain
    EMBO REPORTS, 2007, 8 (05) : 429 - 432
  • [23] From bench to bedside
    Lorenz Trümper
    Medizinische Klinik, 2005, 100 : 53 - 53
  • [24] FROM BENCH TO BEDSIDE
    WILLERSON, JT
    CIRCULATION, 1994, 89 (06) : 2488 - 2488
  • [25] From bench to bedside
    Eckelman, WC
    Vera, DR
    NUCLEAR MEDICINE AND BIOLOGY, 2003, 30 (08) : 793 - 794
  • [26] From Bench to Bedside
    Dwortzan, Mark
    IEEE PULSE, 2011, 2 (04) : 55 - 58
  • [27] Understanding Biology to Tackle the Disease: Multiple Myeloma From Bench to Bedside, and Back
    Bianchi, Giada
    Anderson, Kenneth C.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (06) : 422 - 444
  • [28] B cells biology in systemic lupus erythematosus-from bench to bedside
    Zhao LiDan
    Ye YanXia
    Zhang Xuan
    SCIENCE CHINA-LIFE SCIENCES, 2015, 58 (11) : 1111 - 1125
  • [29] Sclerostin: From bedside to bench, and back to bedside
    Robling, Alexander G.
    Drake, Matthew T.
    Papapoulos, Socrates E.
    BONE, 2017, 96 : 1 - 2